Treatment of essential thrombocythemia in Europe: a prospective long-term observational study of 3649 high-risk patients in the Evaluation of Anagrelide Efficacy and Long-term Safe... by Birgegård, Gunnar, Besses, Carlos, Griesshammer, Martin, Gugliotta, Luigi, Harrison, Claire N, Hamdani, Mohamed, Wu, Jingyang, Achenbach, Heinrich, Kiladjian, Jean-Jacques

Get full text

Corrigendum to “Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional co... by Cuffari, Carmen, Spalding, William, Achenbach, Heinrich, Thakur, Manoj, Gabriel, André

Get full text

Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation by Cuffari, Carmen, Spalding, William, Achenbach, Heinrich, Thakur, Manoj, Gabriel, André

Get full text

Cardiovascular Safety of Anagrelide Hydrochloride versus Hydroxyurea in Essential Thrombocythaemia by Gotic, Mirjana, Egyed, Miklos, Gercheva, Liana, Warzocha, Krzysztof, Kvasnicka, Hans Michael, Achenbach, Heinrich, Wu, Jingyang

Get full text

An open-label phase 2 trial to assess the efficacy, safety and pharmacokinetics of lanthanum carbonate in hyperphosphatemic children and adolescents with chronic kidney disease und... by Wasilewska, Anna, Murray, Rose Ann, Sundberg, Aimee, Uddin, Sharif, Achenbach, Heinrich, Shavkin, Aleksey, Szabó, Tamás, Vergani, Andrea, Umeh, Obi

Get full text

A phase 3b, multicenter, open-label extension study of the long-term safety of anagrelide in Japanese adults with essential thrombocythemia by Kanakura, Yuzuru, Shirasugi, Yukari, Yamaguchi, Hiroki, Koike, Michiaki, Chou, Takaaki, Okamoto, Shinichiro, Achenbach, Heinrich, Wu, Jingyang, Nakaseko, Chiaki

Get full text

Phase III, single-arm study investigating the efficacy, safety, and tolerability of anagrelide as a second-line treatment in high-risk Japanese patients with essential thrombocythe... by Kanakura, Yuzuru, Miyakawa, Yoshitaka, Wilde, Paul, Smith, Jonathan, Achenbach, Heinrich, Okamoto, Shinichiro

Get full text

Effects of treatment cessation and re‐treatment in randomized controlled trials of prucalopride in patients with chronic idiopathic constipation by Hinson, Jimmy, Achenbach, Heinrich, Terreri, Brian, Boules, Mena

Get full text

Corrigendum to "Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional co... by Cuffari, Carmen, Spalding, William, Achenbach, Heinrich, Thakur, Manoj, Gabriel, André

Get full text

SP347MORTALITY AND BONE SAFETY OUTCOMES IN PATIENTS WITH END-STAGE RENAL DISEASE RECEIVING LANTHANUM CARBONATE: A LONG-TERM, OBSERVATIONAL STUDY by Hutchison, Alastair, Thadhani, Ravi, Hall, Gillian, Whelton, Andrew, Achenbach, Heinrich, Wu, Jingyang

Get full text

Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study by Birgegård, Gunnar, Folkvaljon, Folke, Garmo, Hans, Holmberg, Lars, Besses, Carlos, Griesshammer, Martin, Gugliotta, Luigi, Wu, Jingyang, Achenbach, Heinrich, Kiladjian, Jean-Jacques, Harrison, Claire N.

Get full text

Treatment of Essential Thrombocythemia in Europe: An Observational Study of 3649 High-Risk Patients in Exels by Birgegard, Gunnar, Besses, Carlos, Griesshammer, Martin, Gugliotta, Luigi, Harrison, Claire N, Hamdani, Mohamed, Achenbach, Heinrich, Kiladjian, Jean-Jacques

Get full text

Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study by Cascavilla, Nicola, De Stefano, Valerio, Pane, Fabrizio, Pancrazzi, Alessandro, Iurlo, Alessandra, Gobbi, Marco, Palandri, Francesca, Specchia, Giorgina, Liberati, A Marina, D'Adda, Mariella, Gaidano, Gianluca, Fjerza, Rajmonda, Achenbach, Heinrich, Smith, Jonathan, Wilde, Paul, Vannucchi, Alessandro M

Get full text

Impact of JAK2 by Vannucchi, Alessandro M, D'Adda, Mariella, Achenbach, Heinrich, Smith, Jonathan, Pane, Fabrizio, Iurlo, Alessandra, Gaidano, Gianluca, Cascavilla, Nicola, Pancrazzi, Alessandro, Specchia, Giorgina, Fjerza, Rajmonda, Liberati, A. Marina, Wilde, Paul, Gobbi, Marco, De Stefano, Valerio, Palandri, Francesca

Get full text

Effect of anagrelide on cardiac repolarization in healthy volunteers: a randomized, double‐blind, placebo‐ and positive‐controlled, thorough QT study by Troy, Steven, Parks, Virginia, Purkayastha, Jaideep, Gossart, Sophie, Goodman, Daniel B., Achenbach, Heinrich, Armstrong, Martin, Martin, Patrick T.

Get full text

Efficacy of the Irreversible ErbB Family Blocker Afatinib in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI)–Pretreated Non–Small-Cell Lung Cancer Patients... by Hoffknecht, Petra, Tufman, Amanda, Wehler, Thomas, Pelzer, Theo, Wiewrodt, Rainer, Schütz, Martin, Serke, Monika, Stöhlmacher-Williams, Jan, Märten, Angela, Maria Huber, Rudolf, Dickgreber, Nicolas J.

Get full text

Epidemiology of 7375 children and adolescents hospitalized with COVID-19 in Germany, reported via a prospective, nationwide surveillance study in 2020–2022 by Doenhardt, Maren, Hufnagel, Markus, Diffloth, Natalie, Hübner, Johannes, Mauer, René, Schneider, Dominik T., Simon, Arne, Tenenbaum, Tobias, Trotter, Andreas, Armann, Jakob, Berner, Reinhard

Get full text

Afatinib in Non‐Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors by Schumann, Christian, Sebastian, Martin, Sadjadian, Parvis, Märten, Angela, Abdollahi, A., Aries, S.P., Arntzen, C., Atmaca, A., Basara, N., Borchard, B., Bos, M., Brugger, W., Budweiser, S., Corduan, K., Cortes‐Incio, D., Dallmeier, B., Denzlinger, C., Dittrich, I., Engel‐Riedel, W., Faehling, M., Fertl, A., Fischer, J.R., Fleckenstein, D., Folprecht, G., Forstbauer, A., France, Y., Frickhofen, N., Gardizi, M., Gauler, T., Gessner, C., Gökkurt, E., Görner, M., Grah, C., Greeve, J., Greiner, J., Grohé, C., Grüning, W., Guggenberger, D., Heinrich, B., Hense, G., Hoiczyk, M., Huber, R.M., Illerhaus, G., Jacobs, G., Jung, P., Kern, J., Kersten, J., Kiehl, M., Kisro, J., Knipp, H., Ko, Y.D., Koch, J.U., Koehne, C.H., Kollmeier, J., Kommer, A., Körber, W., Krause, G., Krügel, R., Leistner, R., Liebers, U., Lommatzsch, M., Maintz, C., Mohr, M., Neumeister, W., Overbeck, T., Panse, J., Pelzer, T., Peters, K., Planker, M., Reissig, A., Ritter, M., Sadjadian, P., Sandritter, B., Schatz, M., Scheffler, M., Schmid‐Bindert, G., Schneider, C.P., Schneider‐Kappus, W., Schreiber, J., Schütte, W., Schütz, S., Sebastian, M., Serke, M., Staiger, H., Stehle, I., Stengele, K., Stöhlmacher‐Williams, J., Strapatsas, T., Sulzbach, B., Tessmer, A., Thomas, M., Ukena, D., Wagner, B., Wagner‐Hug, D., Witt, C., Wohlleber, M., Wolf, J., Wricke, K., Zaba, O., Zander, I.

Get full text

Recruiting young pre-symptomatic children for a clinical trial in type 1 diabetes: Insights from the Fr1da insulin intervention study by Kick, Kerstin, Assfalg, Robin, Aydin, Susanne, Bechtold-Dalla Pozza, Susanne, Böcker, Dominik, Braig, Sonja, Bunk, Melanie, Dunstheimer, Desiree, Durmashkina, Alevtina, Ermer, Uwe, Gavazzeni, Antonia, Gerstl, Eva-Maria, Heinrich, Melanie, Herbst, Melanie, Kriesen, Yvonne, Kuhnle-Krahl, Ursula, Müller, Herbert, Nellen-Hellmuth, Nicole, Ockert, Christian, Ramminger, Claudia, Sindichakis, Marina, Tretter, Stefanie, Warncke, Katharina, Achenbach, Peter, Ziegler, Anette-G, Hoffmann, Verena S

Get full text

Experience With Afatinib in Patients With Non‐Small Cell Lung Cancer Progressing After Clinical Benefit From Gefitinib and Erlotinib by Schuler, Martin, Fischer, Jürgen R., Grohé, Christian, Gütz, Sylvia, Thomas, Michael, Kimmich, Martin, Schneider, Claus‐Peter, Laack, Eckart, Märten, Angela

Get full text